SecurityXTNT / Xtant Medical Holdings, Inc. (98420P100)
Institutional Owners25
Form N-Q Owners4
Institutional Shares17,160,205 - 94.43% (ex. N-Q)
Common Shares Outstanding18,173,007 shares (as of 2017-09-30) (ex. N-Q)
Institutional Value$ 10,483,000 USD (ex. N-Q)

Institutional Stock Ownership and Shareholders

Xtant Medical Holdings, Inc. (AMEX:XTNT) has 25 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 17,160,205 shares. Largest shareholders include Orbimed Advisors Llc, Northern Trust Corp, Park West Asset Management LLC, Telemetry Investments, L.L.C., Perkins Capital Management Inc, Renaissance Technologies LLC, UBS Group AG, Cambridge Investment Research Advisors, Inc., Vanguard Group Inc, and Northwestern Mutual Wealth Management Co.

Xtant Medical Holdings, Inc. (AMEX:XTNT) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

File DateFormInvestor Opt Prev Shares Current Shares Change
Prev Value (x$1000) Current Value (x$1000) Change
2018-02-13 13F-HR Renaissance Technologies LLC 118,792 291,892 145.72 86 167 94.19
2018-01-29 13F-HR OUTFITTER ADVISORS, LTD. 45,805 35,755 -21.94 33 20 -39.39
2018-02-15 SC 13D/A ORBIMED ADVISORS LLC 2,838,903 9,214,321 224.57
2017-11-21 N-Q Special Opportunities Fund, Inc. (see advisory)
2018-02-14 13F-HR ROYAL BANK OF CANADA 1,692 1,167 -31.03 1 1 0.00
2017-11-02 13F-HR/A-1 Advisor Group, Inc. 3,760 0 -100.00 2 0 -100.00
2018-02-14 13F-HR GOLDMAN CAPITAL MANAGEMENT INC 43,000 0 -100.00 31 0 -100.00
2018-02-07 13F-HR Texas Yale Capital Corp. 10,000 10,000 0.00 7 6 -14.29
2018-02-14 13F-HR NORTHERN TRUST CORP 13,271 2,558,863 19,181.61 10 1,467 14,570.00
2018-02-09 13F-HR BlackRock Inc. 1,455 1,455 0.00 1 1 0.00
2018-02-14 13F-HR BANK OF AMERICA CORP /DE/ 574 574 0.00 0 0
2018-02-14 SC 13G/A Telemetry Investments, L.L.C. 1,416,339 1,416,339 0.00
2018-02-14 13F-HR VANGUARD GROUP INC 59,250 58,150 -1.86 43 33 -23.26
2018-01-26 SC 13G/A PERKINS CAPITAL MANAGEMENT INC 1,702,049 1,131,245 -33.54
2017-11-08 13F-HR D.A. DAVIDSON & CO. 50 0 -100.00 0 0
2018-01-19 13F-HR Winslow, Evans & Crocker, Inc. 15,112 15,112 0.00 10,896 8,652 -20.59
2018-02-22 13F-HR Cambridge Investment Research Advisors, Inc. 64,280 64,280 0.00 46 37 -19.57
2018-02-28 N-Q Ishares Trust (see advisory)
2018-01-31 13F-HR NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 41,693 41,693 0.00 30 24 -20.00
2018-02-06 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 27,720 27,720 0.00 20 16 -20.00
2018-02-09 13F-HR Virtu Financial LLC 19,096 0 -100.00 14 0 -100.00
2017-11-29 N-Q Vanguard Index Funds (see advisory)
2017-11-13 N-Q Bruce Fund Inc (see advisory)
2018-02-14 13F-HR UBS Group AG 87,000 68,000 -21.84 63 39 -38.10
2018-02-09 13F-HR CITADEL ADVISORS LLC 0 13,659 0 8
2018-02-14 13F-HR MORGAN STANLEY 9,000 6,850 -23.89 6 4 -33.33
2018-02-14 SC 13G/A Park West Asset Management LLC 2,188,889
2018-01-25 13F-HR FTB Advisors, Inc. 4,000 4,000 0.00 3 2 -33.33

Form N-Q Advisory - Experimental Feature Here!

We have recently started to include coverage of N-Q filers in our ownership database. N-Q forms are unstructured and difficult for machines to parse into accurate financial data.

However, Because of the large number of these institutions and this difficulty in tracking their positions, they represent a significant, yet hidden, market force. In an effort to widen our ownership coverage and provide greater transparency, we are testing various ways to expose these owners in an accurate manner. This early version of the crawler simply identifies mentions of companies in the N-Q forms.


  • We only list underlying securities (the ordinary shares), even though the actual security held might be a derivative or a related bond issue. For example, although the institution is shown on this security page ( XTNT / Xtant Medical Holdings, Inc. ), the institution may actually own a related security such as a preferred share or a bond. To find out the exact security, click on the institution link and then follow the link to the actual "N-Q".
  • We only list fund sponsors as institutions, even though the security might be held within a fund operated by the listed institution.. For example, the institution listed in the table as the owner is probably a sponsor of a family of ETFs or mutual funds. If so, then this security is owned by a fund or several funds within the family, and not directly owned by the listed institution. The crawler is not yet able to place these holdings within the individual funds. Atain, you must review the actual filing to see the detail.

These limitations are significant but we believe that the increased transparency outweights the limitations. Future revisions of the crawler will resolve these limitations. Use this information at your own risk!

XTNT : Xtant Medical Holdings Stock Analysis and Research Report

Xtant Medical Holdings, Inc. develops, manufactures and markets class-leading regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries.

Xtant believes the following competitive strengths will be key drivers of future growth of Xtant:

Portfolio of Proprietary Technologies: Xtant has developed a comprehensive portfolio of products that address a broad array of spinal pathologies, anatomies and surgical approaches in the complex spine and minimally invasive surgery (“MIS”) markets. To protect company innovative technologies and techniques, Xtant maintains and continues to grow its intellectual property por...

Click for full article
CUSIP: 98420P100